XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED CONDENSED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Other loans, including deposit overdrafts [Member]
Other loans, including deposit overdrafts [Member]
OAEM [Member]
Common Stock [Member]
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings [Member]
Accounting Standards Update 2016-13
Treasury Stock, Common
Treasury Stock, Common
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income [Member]
Accumulated Other Comprehensive Income [Member]
Cumulative Effect, Period of Adoption, Adjustment
Balance Beginning (in shares) at Dec. 31, 2021         12,414,956                
Balance beginning at Dec. 31, 2021 $ 238,604       $ 143,130   $ 126,312     $ (29,029)   $ (1,809)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income 10,141           10,141            
Other comprehensive income, net of taxes (20,131)                     (20,131)  
Dividend Reinvestment and Stock Purchase Plan (in shares)         11,728                
Dividend Reinvestment and Stock Purchase Plan 201       $ 201                
Compensation expense relating to restricted stock (in shares)         32,554                
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 304       $ 304                
Dividends, Common Stock, Cash (4,559)           (4,559)            
Treasury shares purchased (in shares)         (1,084,723)                
Repurchase of common stock (21,600)                 (21,600)      
Balance Ending (in shares) at Jun. 30, 2022         11,374,515                
Balance ending at Jun. 30, 2022 $ 202,960       $ 143,635   131,894     (50,629)   (21,940)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Dividends declared per common share (usd per share) $ 0.40                        
Balance Beginning (in shares) at Mar. 31, 2022         11,401,503                
Balance beginning at Mar. 31, 2022 $ 206,875       $ 143,432   128,555     (50,115)   (14,997)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income 5,618           5,618            
Other comprehensive income, net of taxes (6,943)                     (6,943)  
Dividend Reinvestment and Stock Purchase Plan (in shares)         6,047                
Dividend Reinvestment and Stock Purchase Plan 96       $ 96                
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 107       $ 107                
Dividends, Common Stock, Cash (2,279)           (2,279)            
Treasury shares purchased (in shares)         (33,035)                
Repurchase of common stock (514)                        
Balance Ending (in shares) at Jun. 30, 2022         11,374,515                
Balance ending at Jun. 30, 2022 $ 202,960       $ 143,635   131,894     (50,629)   (21,940)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Dividends declared per common share (usd per share) $ 0.20                        
Financing Receivable, Revolving, Converted to Term Loan $ 6,056   $ 0 $ 0                  
Balance Beginning (in shares) at Dec. 31, 2022 11,259,080       11,259,080 11,259,080              
Balance beginning at Dec. 31, 2022 $ 200,675 $ 198,753     $ 144,069 $ 144,069 139,249 $ 137,327 $ (1,922) (52,689) $ (52,689) (29,954) $ (29,954)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income 8,851           8,851            
Other comprehensive income, net of taxes 2,183                     2,183  
Dividend Reinvestment and Stock Purchase Plan (in shares)         12,763                
Dividend Reinvestment and Stock Purchase Plan 204       $ 204                
Compensation expense relating to restricted stock (in shares)         44,150                
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 398       $ 398                
Dividends, Common Stock, Cash (4,747)           (4,747)            
Treasury shares purchased (in shares)         (199,913)                
Repurchase of common stock $ (3,326)                 (3,326)      
Balance Ending (in shares) at Jun. 30, 2023 11,116,080       11,116,080                
Balance ending at Jun. 30, 2023 $ 202,316       $ 144,671   141,431     (56,015)   (27,771)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Stockholders' Equity, Other $ (1,922)                        
Dividends declared per common share (usd per share) $ 0.42                        
Balance Beginning (in shares) at Mar. 31, 2023         11,202,063                
Balance beginning at Mar. 31, 2023 $ 204,072       $ 144,488   139,115     (54,527)   (25,004)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income 4,694           4,694            
Other comprehensive income, net of taxes (2,767)                     (2,767)  
Dividend Reinvestment and Stock Purchase Plan (in shares)         6,902                
Dividend Reinvestment and Stock Purchase Plan 101       $ 101                
Compensation expense relating to restricted stock (in shares)         0                
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 82       $ 82                
Dividends, Common Stock, Cash (2,378)           (2,378)            
Treasury shares purchased (in shares)         (92,885)                
Repurchase of common stock $ (1,488)                        
Balance Ending (in shares) at Jun. 30, 2023 11,116,080       11,116,080                
Balance ending at Jun. 30, 2023 $ 202,316       $ 144,671   $ 141,431     $ (56,015)   $ (27,771)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Dividends declared per common share (usd per share) $ 0.21                        
Financing Receivable, Revolving, Converted to Term Loan $ 654   $ 0 $ 0